ProfileGDS5678 / 1423164_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 50% 47% 51% 53% 53% 59% 52% 52% 57% 52% 52% 50% 56% 47% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.2448550
GSM967853U87-EV human glioblastoma xenograft - Control 23.1103547
GSM967854U87-EV human glioblastoma xenograft - Control 33.2271751
GSM967855U87-EV human glioblastoma xenograft - Control 43.229553
GSM967856U87-EV human glioblastoma xenograft - Control 53.2399653
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.6159
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.3482652
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.2633852
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.4363157
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.2472452
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.2434552
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.1701250
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.4186156
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.0915347